|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Phase II study of bev- acizumab and ehemoradiation in the preoperative or adjuvant treat-merit of patients with stage IL/III rectalcancer显示文摘 | Spigel DR Bendell JC McCleod M | 2012 | Clin Co[orectal Cancer2012，11，： | 1 |
| 2 | Rationale for chemotherapy,immunother- apy,and checkpoint blockade in SCLC:beyond traditional treatment approaches显示文摘 | Spigel D R Soeinski M A | 2013 | J Thorac Oncol2013，8，5： | 1 |
| 3 | Phase II study of maintenance sunitinih following irinoteean and earboplatin as first -line treatment for patients with ex- tensive- stage small- cell lung cancer 显示文摘 | Spigel D R Greeo F A Rubin M S | 2012 | Lung Cancer2012，77，2： | 1 |
| 4 | Phase II study of bevacizumab and chemoradiation in the preoperative or adjuvant treat-ment of patients with stagelI/III rectalcancer 显示文摘 | Spigel DR 13endell JC McCleod M | 2012 | Clin ColorectalCancer2012，11，7： | 1 |
| 5 | Randomized phase II study of bevacizumab in combination with chemotherapy in previously untreated extensive-stage small-cell lung cancer: results from the SALUTE trial显示文摘 | Spigel D R Townley P M Waterhouse D M | 2011 | J Clin Oncol2011，29，16： | 1 |
| 6 | Rationale for chemotherapy, immunother- apy, and checkpoint blockade in SCLC显示文摘 | Spigel OR Socinski M | 2013 | J Thorac Oncol2013，8，5： | 1 |
| 7 | Market price accounting and depositor discipline: the case of Japanese regional banks显示文摘 | SPIGELE M M YAMORI N | 2007 | Journal of Banking & Finance2007，31，5： | 1 |
| 8 | Randomized phase II study of bevacizumab in combination with chemotherapy in previously untreated extensive-stage small-cell lung cancer: results from the SALUTE trial显示文摘 | Spigel D R Townley P M Waterhouse D M | 2011 | J Clin Oncol2011，29，16： | 1 |
| 9 | Final survival and safety Results from a multicenter,open-label,phase 3b trial of erlotinib in patients with advanced nonsmall cell lung cancer显示文摘 | Spigel DR Lin M O'Neill V | 2008 | Cancer2008，112，： | 1 |
| 10 | Paclitaxel/Carboplatin/gemcitabine versus gemcitabine/vinorelbine ~n advanced non - small - cell lung cancer: a phase Ⅱ/Ⅲ study of the Minnie Pearl Cancer Research Network显示文摘 | GRECO F A SPIGEL D R KUZUR M E | 2007 | Clin Lung Cancer2007，8，8： | 1 |
| 11 | Phase 2, randomized, open-label study of ramucirumab in combination with first-line pemetrexed and platinum chemotherapy in patients with nonsqua- non-small cell lung cancer显示文摘 | Doebele RC Spigel D Tehfe M | 2015 | Cancer2015，121，6： | 1 |
| 12 | Onartuznmab plus erlotinib versus erlotinib in previously treated stage l]I b or 1V NSCLC: Results from the pivotal phase 1Irandomized, muhicenter, placebo-controlled METLung (OAM4971g) global trial 显示文摘 | Spigel DR Edelman M J O'Byrne K | 2014 | J Clin Oncol2014，32，15： | 1 |
| 13 | Phase Ⅱ study of bevacizumab and chemoradiation in the preop- erative or adjuvant treatment of patients with stage Ⅱ/Ⅲ rectal cancer显示文摘 | Spigel DR Bendell JC MeCIeod M | 2012 | Clin Colorectal Cancer2012，11，： | 1 |
| 14 | Phase Ⅱ study of bevacizumab and chemoradiation in the preoperative or adjuvant treatment of patients with stage Ⅱ/Ⅲ rectal cancer显示文摘 | Spigel DR Bendell JC McCleod M | 2012 | Clin Colorectal Cancer2012，11，1： | 1 |
| 15 | Phase 2, ran?domized, open -label study of ramucirumab in combination with first-line pemetrexed and platinum chemotherapy in patients with nonsquamous, advanced/metastatic non - small cell lung cancer显示文摘 | DOEBELE RC SPIGEL D TEHFE M et ol | 2015 | Cancer2015，121，6： | 1 |
| 16 | Phase II study of oral topoteean plus bevaeizumab (topo-bev) for second-line treat- merit of small cell lung cancer ( SCLC ) 显示文摘 | Waterhouse D M Morgan SK Spigel DR | 2010 | J Clin Oneol2010，28，： | 1 |
| 17 | Final survival and safety results from a multicenter, open-lable, phase 3b trial of erlotinib in patients with advanced non-small-cell lung cancer 显示文摘 | Spigel DR Lin M OrNeill V | 2008 | Cancer2008，112，12： | 1 |
| 18 | Final survival and safety results from a muhicenter, open-label, phase 3b trial of erlotinib in patients with advanced non-small cell lung cancer 显示文摘 | Spigel DR Lin M O'Neill V | 2008 | Cancer2008，112，12： | 1 |
| 19 | Phase lI study of bevacizum- ab and chemoradiation in the preoperative or adjuvant treatment of pa-tients with stage Ⅱ/Ⅲ rectal cancer 显示文摘 | Spigel DR Bendell JC McCleod M | 2012 | Clin Colnrectal Cancer2012，11，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员